Tag: RGS

Regeneus Kyocera Progenza knee osteoarthritis OA licence ASX RGS stem cell

Regeneus signs agreement with Kyocera for licensing of Progenza knee osteoarthritis drug to Japanese market

Clinical-stage regenerative medicine company Regeneus (ASX: RGS) has signed a licence and collaboration agreement with Kyocera Corporation to develop and commercialise its lead stem cell platform tech...
Regeneus ASX RGS Chinese patent biomarkers stem cell therapy monitoring disease progression

Regeneus receives Chinese patent for biomarkers in monitoring disease progression for stem cell therapy

Regenerative medicine company Regeneus (ASX: RGS) has reached a significant milestone in its mission to market its proprietary biomarkers in China. The company is developing a portfolio of innovati...
Knee osteoarthritis japanese patent regeneus progenza stem cell technology

Japanese patent office grants key patent for Regeneus’ Progenza stem cell technology

Regeneus (ASX: RGS) today announced that the Japanese patent office has issued a decision to grant a key patent covering the composition, manufacture and use of Progenza stem cell technology. Proge...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS